DMG GPW Periodic report · PAP Biznes
Dr. Miele Cosmed Group SA (DMG) · Q1 2026 results and valuation
Share price: 1.80 zł · 2026-11-10
Results Q1 2026 vs Q1 2025 · year over year · published 28 May 2026 and 23 May 2025
Net income down 40.3% year on year. The report's language is unchanged.
Only a basic analysis is available for this company at the moment.
1 · Numbers
−40.3%
Net income vs Q1 2025
Net income 2.4M vs 4.0M
Revenue −6.7%
2 · How the report reads
Unchanged
Language tone vs last period
Report language: restrained for a company report — about as upbeat as in Q1 2025.
Weak signal: formal report language, not a call.
3 · What stood out Nothing unusual flagged this period.
Valuation
Is Dr. Miele Cosmed Group SA undervalued?
Reverse DCF. Free cash flow from the last full fiscal year (2025-12-31), grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.
At 8.3% growth a year (3-year revenue growth), the model's fair value is 2.55 zł a share — the stock trades 29% below it. Today's price assumes 4.4% growth a year.
Current price
1.80 zł
close of 2026-11-10
Market implies growth of iThe yearly free-cash-flow growth, for the next 10 years, that today’s share price already assumes. If you believe the company grows faster than this, the stock is cheap under this model; slower, and it is expensive.
+4.4% for 10 yrs
Fair value / share
2.55 zł
Buy below
1.92 zł
Price vs fair value
Undervalued 29%
Price vs buy-below price
Undervalued 6%
Read between the lines
No major shifts flagged this period.
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.
Restrained for a company report — about as upbeat as in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.
Sentences that drove the tone
“The Dominating Entities continuously monitor internal and external threats and risks that may have a significant impact on the activities of the Capital Group.”
“The planned further development of the Capital Group is through the growth of sales revenues from brands and private labels.”
“Value enhancement for shareholders – by acquiring shares, the Company will be able to increase the value of the shares remaining in circulation, which will increase the profit and the dividend per shareholder.”
Full figures
PLN · PAP Biznes report (2026-05-28)
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | 82.3M | 88.2M | −6.7% |
| Gross profit | 2.9M | 6.9M | −58.2% |
| Operating income | 3.0M | 5.0M | −39.7% |
| Net income | 2.4M | 4.0M | −40.3% |
| EPS | 0.03 | 0.05 | −40.0% |
| P/E today 9.2 | 10.1 | 9.5 | +0.6 |
Topics
Topics are drawn from the full report text, not management commentary.
Most discussed now
- For the year 2025, including the recommendation of the amount to be distributed among the shareholders (dividend), the Management Board Dr.
- The primary and exclusive scope of business of the companies in the Capital Group is the production and sale of cosmetic and toilet…
- The standard will require the disclosure of all metrics used by the entity in a single note, including the calculation method of the metric.
- Identification of threats and risks which, in the issuer's opinion, will have an impact on the results achieved over the perspective of at…
- The changes apply to annual periods beginning on January 1, 2026.
Faded since Q1 2025
- Fading Upon obtaining, by the previously entered into agreement between Dr.
- Fading Changes in the Capital Group structure as a result of the merger of business entities, acquisition or sale of Capital Group units…
- Fading Approved by the RMSR for use after January 1, 2026.
Latest announcements
Official filings, newest first.
- Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia na dzień 15 października 2026r. Projekty uchwał Nadzwyczajnego Walnego Zgromadzenia. · ESPI 17/2026
- Half-year report · ESPI periodic
- Istotna zmiana umowy znaczącej · ESPI 16/2026
- Uzyskanie przez umowę zawartą przez jednostkę zależną Emitenta statusu umowy znaczącej · ESPI 15/2026
- Uzyskanie przez umowę zawartą przez Emitenta statusu umowy znaczącej · ESPI 14/2026
- Rejestracja zmian w Statucie Dr. Miele Cosmed Group S.A. · ESPI 13/2026
- Zawarcie przez Emitenta umowy znaczącej · ESPI 12/2026
- Zawarcie ugody pozasądowej z AB Industry S.A. oraz podjęcie działań zmierzających do zawarcia ugody sądowej · ESPI 11/2026